• +1-646-491-9876
    • +91-20-67278686

    Search

    Hypothyroidism Pipeline Review H1 2017

    Hypothyroidism Pipeline Review H1 2017

    • Report Code ID: RW0001799291
    • Category Pharmaceuticals
    • No. of Pages 29
    • Publication Month May-17
    • Publisher Name Global Markets Direct
    Hypothyroidism - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Hypothyroidism - Pipeline Review, H1 2017, provides an overview of the Hypothyroidism (Hormonal Disorders) pipeline landscape.

    Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesn't produce enough of certain important hormones. Signs and symptom include fatigue, constipation, dry skin, puffy face, muscle weakness, muscle aches, tenderness and stiffness, pain and stiffness. Risk factors include autoimmune diseases, thyroid surgery, radiation therapy and family history of thyroid disease.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Hypothyroidism - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hypothyroidism (Hormonal Disorders) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Hypothyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypothyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, IND/CTA Filed and Preclinical stages are 1, 1 and 5 respectively.

    Hypothyroidism (Hormonal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Hypothyroidism (Hormonal Disorders) .
    - The pipeline guide reviews pipeline therapeutics for Hypothyroidism (Hormonal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Hypothyroidism (Hormonal Disorders) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Hypothyroidism (Hormonal Disorders) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Hypothyroidism (Hormonal Disorders)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Hypothyroidism (Hormonal Disorders) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Hypothyroidism (Hormonal Disorders) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Hypothyroidism - Overview
    Hypothyroidism - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Products under Development by Companies
    Hypothyroidism - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Hypothyroidism - Companies Involved in Therapeutics Development
    Genexine Inc
    Synthonics Inc
    Titan Pharmaceuticals Inc
    Hypothyroidism - Drug Profiles
    (levothyroxine sodium + liothyronine sodium) - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BCT-305 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    GX-30 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    levothyroxine sodium SR - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    liothyronine sodium - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    liothyronine sodium SR - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    liothyronine sodium SR - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Hypothyroidism - Dormant Projects
    Hypothyroidism - Product Development Milestones
    Featured News & Press Releases
    Nov 16, 2015: Titan Pharmaceuticals Adds Proneura Implant For Hypothyroidism To Product Development Pipeline
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Hypothyroidism, H1 2017
    Number of Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Hypothyroidism - Pipeline by Genexine Inc, H1 2017
    Hypothyroidism - Pipeline by Synthonics Inc, H1 2017
    Hypothyroidism - Pipeline by Titan Pharmaceuticals Inc, H1 2017
    Hypothyroidism - Dormant Projects, H1 2017

    List of Figures

    Number of Products under Development for Hypothyroidism, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Targets, H1 2017
    Number of Products by Stage and Targets, H1 2017
    Number of Products by Mechanism of Actions, H1 2017
    Number of Products by Stage and Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    Genexine Inc
    Synthonics Inc
    Titan Pharmaceuticals Inc

    Request for Sample

    Report Url http://www.reportsweb.com//hypothyroidism-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//hypothyroidism-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//hypothyroidism-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments